Key facts
- This page summarizes Cedrik Michael Britten's Form 3 filing for Immatics N.V. (IMTX).
- 0 reported transactions and 9 derivative rows are listed below.
- Accepted by SEC: 18 Mar 2026, 19:39.
Cedrik Michael Britten - 18 Mar 2026 Form 3 Insider Report for Immatics N.V. (IMTX)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- IMTX
- Reported as of
- 18 Mar 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Edward Sturchio, attorney-in-fact for Cedrik Michael Britten
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Cedrik Michael Britten filed Form 3 for Immatics N.V. (IMTX) on 18 Mar 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002109070
Primary reporting owner
Britten Cedrik Michael
- Relationship
- Chief Medical Officer
- Address
- PAUL-EHRLICH-STR. 15, TUBINGEN, GERMANY
- Signature
- /s/ Edward Sturchio, attorney-in-fact for Cedrik Michael Britten
- Signature date
- 18 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IMTX
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 250
- Date
- 18 Mar 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IMTX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 94,329
- Exercise price
- $10.00
- Footnotes
- F1
IMTX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 255,000
- Exercise price
- $10.00
- Footnotes
- F2
IMTX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 49,000
- Exercise price
- $9.68
- Footnotes
- F1
IMTX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 98,000
- Exercise price
- $11.00
- Footnotes
- F1
IMTX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 112,500
- Exercise price
- $9.75
- Footnotes
- F3
IMTX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 155,000
- Exercise price
- $9.06
- Footnotes
- F4
IMTX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 150,000
- Exercise price
- $8.06
- Footnotes
- F5
IMTX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 200,000
- Exercise price
- $9.32
- Footnotes
- F6
IMTX
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 50,000
- Exercise price
- $0.000000
- Footnotes
- F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
These options to purchase ordinary shares of the Issuer ("Ordinary Shares," and each such option, an "Option") are fully vested.
Footnote F2
These Options are eligible to be earned based on the achievement of specified market capitalization performance hurdles and service-vesting conditions. The service-vesting conditions are satisfied as to 25% of the Options on the first anniversary of the grant date, June 30, 2020, and 6.25% of the Options on each quarterly anniversary of such date over the following three years.
Footnote F3
These Options vest 25% on the first anniversary of the grant date, December 13, 2022, then in 12 equal quarterly installments over the following three years.
Footnote F4
These Options vest 25% on the first anniversary of the grant date, December 5, 2023, then in 12 equal quarterly installments over the following three years.
Footnote F5
These Options vest 25% on the first anniversary of the grant date, December 3, 2024, then in 12 equal quarterly installments over the following three years.
Footnote F6
These Options vest 25% on the first anniversary of the grant date, January 8, 2026, then in 12 equal quarterly installments over the following three years.
Footnote F7
Each restricted stock unit ("RSU") represents a contingent right to receive one Ordinary Share. These RSUs vest in four equal annual installments on each anniversary of the grant date, January 8, 2026.
SEC remarks
Exhibit List - Exhibit 24.1 - Power of Attorney